FDA Approves Spryte’s Pivotal Aneurysm Imaging Trial
Spryte Medical secured FDA IDE approval to launch INSYTE, a pivotal trial evaluating its neuro optical coherence tomography system...
ACRP Honored with Bronze Prize at 5th Anthem Awards
The Association of Clinical Research Professionals secured a Bronze in the Health: Global Awareness category at the 5th Anthem...
Physiotherapy Equipment Market to Surpass $9.45B by 2029
The physiotherapy equipment market generated $6.26 billion in 2023, is estimated at $6.70 billion for 2024, and is projected...
Longeveron Alzheimer’s Data Selected for CTAD Presentation
Longeveron will present new CLEAR MIND study results indicating reductions in brain neuroinflammation following treatment with laromestrocel (Lomecel-B) in...
Breakthrough TARA-002 Trial Sees Positive Pediatric Results
In an interim readout from the Phase 2 STARBORN-1 trial in pediatric lymphatic malformations, 100% of the eight patients...
Rethinking EDC: Why AI Demands a New Foundation for Clinical Data Management
At Veeva R&D and Quality Summit 2025, we spoke with Manny Vazquez, Senior Director of Clinical Data Strategy at...
NIH Funds Trial for Non-Surgical Knee Osteoarthritis Relief
Steadman Philippon Research Institute and Neuromuscular Dynamics have initiated a randomized, at-home trial in knee osteoarthritis testing an eight-week...
Kyowa Kirin Presents New Mogamulizumab Research at ASH 2025
No efficacy or safety rates were disclosed ahead of ASH, but the headline is a Phase 2, single-arm evaluation...
Radiopharm Begins Promising Phase 1 Prostate Cancer Trial
Radiopharm Theranostics has received ethics approval from Australia’s Bellberry HREC to initiate a first-in-human Phase 1 study of RAD...
Annovis Announces FDA Meeting for Parkinson’s, Alzheimer’s
No new efficacy or safety data accompanied Annovis Bio’s update. The company reported two regulatory developments: FDA has scheduled...